International Murex Completes Financing

	International Murex Technologies Corp. (NASDAQ), formed through the acquisition of the diagnostics business of Wellcome plc, is a provider of in vitro immunodiagnostic products
	Murex retained TM Capital to arrange financing to support the growth of the company
	TM Capital arranged $15 million of senior credit facilities for Murex for working capital and expansion purposes